We are seeing patients in-person and through Video Visits. Learn more about how we’re keeping you safe and please review our updated visitor policy. Please also consider supporting Weill Cornell Medicine’s efforts to support our front-line workers.

Reclaim™ Deep Brain Stimulation (DBS) Therapy for Obsessive-Compulsive Disorder (Humanitarian Use Device)

You are here

Patients with obsessive-compulsive disorder may respond to either medication or psychotherapy. However, some patients either do not respond well to even multiple medications or they become resistant and their symptoms return over time. Some of these patients can have symptoms that are sufficiently severe that they prevent them from performing most normal activities of living and may even prevent them from leaving their homes. Therefore, there is great need for additional therapies to help these patients who have few other medical options.

This study will be providing deep brain stimulation therapy to alter pathological functioning of circuitry involved in causing medically resistant obsessive-compulsive disorder. Brain stimulation involves the use of an implanted lead or leads to deliver electrical stimulation to parts of the brain. Medtronic, the company providing the device, has received FDA approval to market the Reclaim DBS therapy for treatment of OCD under a Humanitarian Device Exemption (HDE).

Principal Investigator: Michael Kaplitt, M.D.

Phone: 212-746-4966